Xiangli Zhao

5PUBLICATIONS
12CO-AUTHORS
Medical biochemistry - lipidsGenetically modified animalsNeurology and neuromuscular diseasesAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 21, 2024
Dietary pyruvate targets cytosolic phospholipase A2 to mitigate inflammation and obesity in mice.

Sadaf Hasan, Nabil Ghani, Xiangli Zhao

|Dec 27, 2022
PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, GBA1 mutation-associated pathologies and diseases.

Xiangli Zhao, Yi Lin, Benjamin Liou

|Jan 21, 2022
Analysis of the Biomarkers for Neurodegenerative Diseases in Aged Progranulin Deficient Mice.

Xiangli Zhao, Sadaf Hasan, Benjamin Liou

|Oct 23, 2021
Cytosolic Phospholipase A2 Is Required for Fexofenadine's Therapeutic Effects against Inflammatory Bowel Disease in Mice.

Xiangli Zhao, Ronghan Liu, Yuehong Chen

|Feb 05, 2021
Involvement of CD26 in Differentiation and Functions of Th1 and Th17 Subpopulations of T Lymphocytes.

Xiangli Zhao, Wenhan Wang, Kai Zhang

Pageof 1